KRPIA's head of policy position, which had remained vacant for about a year, is soon set to be filled.

According to industry sources, the Korean Research-based Pharmaceutical Industry Association (KRPIA) recently named In-Hwa Choi (60), current Access and Policy Head at Roche, to oversee the association's policy business. Choi will succeeding the former Director Min-Young Kim (53, current Director of Market Access at Gilead Sciences Korea) who resigned in February last year.

The new Director Choi will retire from her role as Access & Policy Cluster Lead at Roche this month (January).

KRPIA has been operating without a policy lead for about a year after its former Director